EPAM Systems Inc vs Tenet Healthcare Corporation — how do they compare? EPAM Systems Inc trades at $113.24 (market cap $5.87B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3.6× EPAM Systems Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, EPAM Systems Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EPAM Systems Inc for 37 Days and Tenet Healthcare Corporation for 15 Days on average.
| EPAM | THC | |
|---|---|---|
Market Cap | $5.87B | $20.98B |
Volume | 847,420 | 428,008 |
Sector | Technology | Health |
52-Week High | $221.40 | $280.77 |
52-Week Low | $76.04 | $161.37 |
Typical Hold Time | 37 Days | 15 Days |
Enterprise Value | $5.24B | $32.06B |
Signals from Pluang's Aura AI — not financial advice
EPAM trades at $113.86, up 5.11% on the day, with a bullish technical signal and strong quarterly earnings beats. Revenue grew to $5.46B in 2025, though net income margin compressed to 6.92%. The company maintains solid profitability with ROE of 11.18% and trades at a P/E of 15.45, below industry averages. Recent news highlights AI-native revenue growth and activist investor pressure for share buybacks.
The outlook is positive with a consensus price target of $119, representing 4.5% upside. Key catalysts include Q3 2026 earnings and AI service expansion, but risks involve North American growth slowdown and competitive pressures in digital transformation services.
Tenet Healthcare (THC) trades at $260.57, up 0.28% with strong technical momentum and bullish moving averages. The stock demonstrates robust fundamentals with consistent earnings beats, a 10.07 P/E ratio, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 earnings scheduled for October 29. Technical indicators show support at $257 and resistance at $262, with overall bullish sentiment from analysts.
THC presents a compelling investment case with strong profitability metrics and analyst consensus pointing to 8.7% upside to the $283.36 price target. Key risks include declining net cash flow and potential surgical volume pressures. The combination of value pricing, earnings momentum, and institutional support suggests continued upward potential, though investors should monitor cash flow sustainability and Q3 earnings results.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →